StockData

Endonovo Therapeutics, Inc. (ENDV) stock

ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $135.08KP/E –Yield –

Endonovo Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Endonovo Therapeutics's price to sales ratio was 0.1× on Oct 19, 2026, against 0.2× a year earlier. Over the last 5 years it ranged from 0.0× to 210.7×, with a median of 3.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.1×+0.0
2025Dec 31, 20250.1×−0.4
2024Dec 31, 20240.5×−10.3
2023Dec 29, 202310.8×−190.9
2022Dec 30, 2022201.7×+188.9
2021Dec 31, 202112.8×+11.7
2020Dec 31, 20201.1×−58.9
2019Apr 30, 201960.1×–

More Endonovo Therapeutics figures

See a number that looks wrong?